Arjo Products
VTE prevention solutions
VTE is a serious condition that causes death and disability worldwide, with 10 million cases each year.
In order to safeguard the well-being of at-risk patients, comprehensive venous thromboembolism prevention strategies that take into account individual clinical needs are essential.
Meet Stefan Elvenes, former ice hockey player and VTE patient
Stefan was diagnosed with a blood clot shortly after retiring. At 37 years old, fit and healhty, it was a complete shock to be faced with this life threatening condition.
Flowtron ACS900 is proven to make a difference
Feedback from 188 users at 32 hospitals in Australia, France, the UK, and USA concludes that the Flowtron ACS900 and Tri Pulse system make a positive difference for VTE prevention therapy.
What patients need to know about VTE prevention
Help patients understand the risks of VTE, the role of prevention during their hospital stay, and what to be aware of after leaving the hospital with this patient leaflet.
Safe, convenient and flexible VTE Prevention Solution
VTE is a serious condition that causes death and disability worldwide, with 10 million cases each year.
In order to safeguard the well-being of at-risk patients, comprehensive venous thromboembolism prevention strategies that take into account individual clinical needs are essential.
The burden of VTE
Critical care, cancer, obstetrics, bariatric, stroke patients, and those subject to 30+ minutes surgical procedures in general, are all at risk of VTE. You can download our brochure here.
Key clinical evidence supporting the use of IPC
We invite you to review this clinical resource providing examples of some of the key evidence supporting the use of IPC and specifically the Flowtron Active Compression System as part of a VTE prevention programme. You can download our clinical evidence brochure.
VTE ACS900 Compliance Monitoring
Flowtron ACS900 Compliance Monitoring will help to ensure effective delivery of IPC therapy and support clinical outcomes.
